लोड हो रहा है...
TAM Receptor Tyrosine Kinases as Emerging Targets of Innate Immune Checkpoint Blockade for Cancer Therapy
Cancer immunotherapy utilizing T cell checkpoint inhibitors has shown tremendous clinical success. Yet this mode of treatment is effective in only a subset of patients. Unresponsive patients tend to have non-T cell inflamed tumors that lack markers associated with the activation of adaptive anti-tum...
में बचाया:
| में प्रकाशित: | Immunol Rev |
|---|---|
| मुख्य लेखकों: | , , |
| स्वरूप: | Artigo |
| भाषा: | Inglês |
| प्रकाशित: |
2017
|
| विषय: | |
| ऑनलाइन पहुंच: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5381815/ https://ncbi.nlm.nih.gov/pubmed/28258690 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/imr.12522 |
| टैग : |
टैग जोड़ें
कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!
|